1. Immune response and possible therapeutics in COVID-19. Issue 2 (4th January 2021) Authors: Dutta, Anindya; Roy, Ananya; Roy, Laboni; Chattopadhyay, Samit; Chatterjee, Subhrangsu Journal: RSC advances Issue: Volume 11:Issue 2(2021) Page Start: 960 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Peptide therapeutics in the management of metastatic cancers. Issue 33 (2nd August 2022) Authors: Bose, Debopriya; Roy, Laboni; Chatterjee, Subhrangsu Journal: RSC advances Issue: Volume 12:Issue 33(2022) Page Start: 21353 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Targeting Ca2+ signaling: A new arsenal against cancer. Issue 3 (March 2022) Authors: Panda, Suman; Chatterjee, Oishika; Roy, Laboni; Chatterjee, Subhrangsu Journal: Drug discovery today Issue: Volume 27:Issue 3(2022) Page Start: 923 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗